Medical Animation Dermatology Animation

Survival Of Melanoma Cells Promoted By Gene Required For Radiation-Induced Protective Pigmentation
Scientists have new insight into the response of human skin to radiation and what drives the most aggressive and deadly form of skin cancer. The research, published by Cell Press in the November 21st issue of the journal Molecular Cell, may be useful in the design of new strategies for prevention of malignant melanoma. The process of tanning involves synthesis of the pigment melanin by skin cells known as melanocytes.

FDA Advisory Committee Provides Opinion On Oritavancin For The Treatment Of Complicated Skin And Skin Structure Infections
Targanta Therapeutics Corporation (Nasdaq: TARG) today announced that oritavancin, the Company's investigational antibiotic therapy for the treatment of complicated skin and skin structure infections (cSSSI) caused by gram-positive pathogens, including methicillin resistant Staphylococcus aureus (MRSA), received a mixed review from the United States Food and Drug Administration's (FDA) Anti-Infective Drugs Advisory Committee.

Patients Experienced Nearly A 70% Reduction In Pain When Using MPM Medical's Regenecare Wound Care Gel
A recent clinical study found that patients experienced nearly a 70% reduction in pain when MPM Medical Inc.'s Regenecare HA® hydrogel was used prior to and during the changing of their wound dressings. The finding comes at a time when a cross-section of American thought leaders are calling the lack of proper pain management a national healthcare crisis. In answer, members of Congress have united to sponsor the National Pain Care Policy Act of 2008 (H.R.

Metastatic Melanoma - Provectus Adds 6th Center To Phase 2 Clinical Trial Of PV-10
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, has begun recruitment for its Phase 2 clinical trial of the Company's lead oncology agent PV-10 at a sixth major center located at the California Pacific Medical Center, in San Francisco, CA. David Minor, M.D. will serve as principal investigator at the new center covering the western United States.

Michelson Diagnostics To Demonstrate Prototype Hand-Held OCT Probe At BIOS 09
Michelson Diagnostics has announced that it will demonstrate its prototype multi-beam Optical Coherence Tomography (OCT) probe at the BIOS Exhibition at SPIE Photonics West, San Jose, 24-25th January 2009 (Stand 8731). More than one variant of the new probe will be launched later in 2009, including a dermal version (with X-Y scanning, to enable 3D mapping of skin lesions) and a version equipped with a rigid endoscope, suitable for oral applications.

Australia/New Zealand Join Forces On New Treatment Guidelines For Melanoma
In a cross-Tasman first, Australia and New Zealand have collaborated with a joint approach to the development of treatment guidelines for cancer, to be launched today (19/11) at the Clinical Oncological Society of Australia Annual Scientific Meeting in Sydney.

Vitamin Boosts Immunity Against Skin Cancer
Nicotinamide (VitB3), a vitamin found in common foods like meats, nuts, grains and cereals, may provide the next advance in skin cancer prevention, according to new research from the University of Sydney. Presenting the results of a trial to the Clinical Oncological Society of Australia's Annual Scientific Meeting today (19 Nov), Associate Professor Diona Damian said tests had shown the vitamin prevented damage from ultraviolet (UV) radiation by protecting the immune system.

Chronic Plaque Psoriasis - 2nd Case Of Progressive Multifocal Leukoencephalopathy In A Raptiva Patient
Genentech, Inc. (NYSE:DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform dermatologists and neurologists of a 2nd case of progressive multifocal leukoencephalopathy (PML) which resulted in the death of a 73-year old woman who had received Raptiva® (efalizumab) for approximately four years for treatment of chronic plaque psoriasis.

Simple Steps To Help Your Skin Weather The Winter Season - University Of The Sciences In Philadelphia
Cracking, chaffing, dry patches, and itchiness - all are unpleasant symptoms of dry and irritated skin that often comes with winter. As temperatures drop, the wind howls, and humidity levels hit an all-year low, our skin requires extra attention and care to stay healthy.

Physicians Coalition For Injectable Safety Warns Consumers About Cosmetic Injection Discounts
Bargains on consumer goods and services may be designed to encourage spending in tough economic times, however when related to cosmetic injections like Restylane, Juvederm or Botox, the multi-specialty Physicians Coalition for Injectable Safety warns that discounts raise a red flag.

Treatment Found For Psoriasis In Traditional Chinese Medicine
According to a study published in the November issue of Archives of Dermatology, an effective treatment for plaque-type psoriasis can be found in traditional Chinese medicine. Yin-Ku Lin, M.D. (Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan) and colleagues found that an ointment based on the dark-blue, plant-based powder indigo naturalis can be used treat the skin condition.

Survey Of Beachgoers' Tanning Habits Should Help Interventions To Prevent Skin Cancer
A study published in the November issue of Archives of Dermatology seeks to determine which beachgoers would benefit from targeted interventions to reduce skin cancer risk by identifying sun-protection practices and risk profiles. In the past 30 years, the Unites States has seen a rapid increase in the incidence of skin cancer and death due to outdoor exposure to ultraviolet radiation (UVR).

SciClone Agreement With FDA On Special Protocol Assessment For Phase 3 Thymalfasin Trial In Stage IV Melanoma
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that the Company and the U.S. Food and Drug Administration (FDA) have reached agreement on the design of a phase 3 registration trial for thymalfasin as a potential treatment for stage IV melanoma. Based on the FDA's review, the agency agrees that the design and planned analysis of SciClone's study adequately addresses the objectives necessary to support a regulatory submission.

Skin Cancer - Study Shows Novel Light Device Detects Cancerous Lesions From Normal Tissue
Researchers report promising results for the viability of a portable, handheld device using a specialized light technique that may enhance the differential diagnosis of non-melanoma skin cancers, inflamed scar tissue and normal skin in vivo.

Main Reason Teens Get Sunburnt "I Forgot To Protect Myself"
Teens continue to put themselves at unnecessary risk of skin cancer by spending excessive time in the sun and forgetting to protect themselves, according to new Cancer Council research. Findings from the Cancer Council's National Sun Protection Survey released today show teens spend an average of two hours (1hr 51mins) in the sun during peak UV, with almost a third who get sunburnt saying they "forgot" to protect themselves.